Vinge advises in connection with sale of shares in Advania AB

Vinge advises the existing shareholders in Advania AB In connection with their sale of shares in Advania to Via Equity and PFA, the largest commercial pension company in Denmark.

Vinge advised IBT on its Nasdaq Stockholm main market listing

The shares of Infant Bacterial Therapeutics AB (publ) have been admitted to trading on the main market of Nasdaq Stockholm (Mid Cap).

Vinge advises Skånska Energi on the takeover bid by Acsnacs

Acsnacs Energi AB has made a recommended cash offer to the shareholders of Skånska Energi AB (publ). 

Vinge advised BIMobject on directed share issue

BIMobject AB (publ) has completed a directed share issue of SEK 240 million to EQT Ventures.    

Vicore Pharma Holding acquires INIM Pharma

Vinge has advised the shareholders of INIM Pharma in connection with the sale of the company to Vicore Pharma Holding, which is listed on First North.

Vinge has advised Autoliv and Veoneer

Vinge has advised Autoliv, Inc. (“Autoliv”) and Veoneer, Inc. (“Veoneer”) in connection with the spin-off and listing of Veoneer on the New York Stock Exchange and Nasdaq Stockholm. First day of regular trading of Veoneer was July 2, 2018.

Vinge advises Calliditas Therapeutics in connection with the listing on Nasdaq Stockholm’s main market

Vinge advises Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”) in connection with the listing of the company’s shares on Nasdaq Stockholm’s main market. Trading in Calliditas Therapeutics’ shares on Nasdaq Stockholm commences today, 29 June 2018.

Vinge advises Net Gaming in connection with its listing on Nasdaq First North Premier

Vinge advises Net Gaming Europe AB (publ) in connection with its list change from Spotlight Stock Market (previously AktieTorget) to Nasdaq First North Premier.

Vinge advises Nuevolution in connection with its listing on Nasdaq Stockholm

Vinge advises Nuevolution AB (publ) in connection with its list change from Nasdaq First North Premier to Nasdaq Stockholm’s main market.

Vinge advises Danske Bank and SEB in relation to Raketech’s listing on Nasdaq First North Premier

Vinge advises Danske Bank A/S, Danmark, Sverige Filial and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Raketech Group Holding plc – a marketing actor whose primary business involves using its online products to influence iGaming market users who are interested in sports and gambling and to guide them towards the best gambling services – on Nasdaq First North Premier. 

Vinge advises Nordea and SEB in relation to Better Collective’s listing on Nasdaq Stockholm

Vinge advises Nordea Bank AB (publ) and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Better Collective A/S – one of the leading affiliates on the European iGaming affiliate market – on Nasdaq Stockholm.

Vinge has advised Cellink in a directed new issue of shares of MSEK 100

Vinge has advised Cellink AB (publ) in connection with a directed new issue of shares to Swedish and internationally well-reputed investors such as the Swedish Fourth AP Fund (AP4), Carl Bennet AB, Claes Dinkelspiel and Handelsbanken Fonder.

Vinge advises Opus Group in conjunction with issuance of bonds

Opus Group AB (publ) (”Opus”) has issued a so called senior unsecured bond in the amount of MSEK 500 MSEK with a term of four years on the Nordic market.

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

Vinge advises Tele2 in the merger with Com Hem

Tele2 AB (publ) and Com Hem Holding AB (publ) announced on 10 January 2018 that they have agreed on a combination through a statutory merger in accordance with the Swedish Companies Act.